Free tool
Drug Trial Radar: Infectious disease and vaccines
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
4
Not yet recruiting, industry sponsors, Infectious disease and vaccines, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed502
4 trials
Showing 1 to 4, recently updated first.
- A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy AdultsNot yet recruiting
Microneedle Solutions LtdIndustry
NCT07624669 · 30 participants (planned) · Start Jan 2027 · Primary completion Mar 2027
Drug: Tetanus-containing vaccine · For: Vaccine Delivery; Tetanus
- B-Ensure: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study ParticipantsNot yet recruiting
GlaxoSmithKlineGSK (GSK)
NCT07908459 · 303 participants (planned) · Start Dec 3, 2026 · Primary completion Dec 3, 2030
Drug: Bepirovirsen · For: Hepatitis B
- Study of BIC/LEN FDC Versus Stable Baseline Regimens in Virologically Suppressed People With HIVPivotal-lookingNot yet recruiting
Gilead SciencesGilead Sciences (GILD)
NCT07908446 · 400 participants (planned) · Start Nov 2026 · Primary completion Jul 2028
Drug: BIC/LEN FDC; Lenacapavir and 1 more · For: HIV-1 Infection
- Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure ScenarioNot yet recruiting
Emergent BioSolutionsIndustry
NCT02177721 · 100 participants (planned) · Start Jan 2027 · Primary completion May 2035
Drug: Sample Collection · For: Infections, Bacterial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.